TreatmentsWeight lossAll treatments
Weight loss and GLP-1 medications
Weight-management visits are one of the most common reasons people look at telehealth. Clinicians on platforms such as Ro, Hims, and Hers may discuss GLP-1 medicines when they fit a person’s health history. DoctorsHome explains those names. It does not decide who should take them.
- Semaglutide and tirzepatide are the GLP-1 medicines people ask about most.
- Some products are approved for weight management. Others are approved for type 2 diabetes and are sometimes considered off-label.
- A licensed clinician reviews medical history before any prescription. This site cannot do that.
Medications people ask about
These are brand and generic names that show up on major telehealth sites. A prescription, if any, comes from a licensed clinician. Listing a name here is not a suggestion to take it.
- Semaglutide, including Wegovy, which is approved for weight management in eligible adults
- Oral semaglutide options that some platforms describe as a Wegovy pill
- Ozempic (semaglutide), approved for type 2 diabetes and sometimes considered off-label for weight
- Tirzepatide, including Zepbound, which is approved for weight management in eligible adults
- Mounjaro (tirzepatide), approved for type 2 diabetes and sometimes considered off-label for weight
- Orforglipron (Foundayo), an oral GLP-1 some platforms list for weight management
Who usually looks this up
Adults who want to understand injectable and pill forms before they talk with a clinician. Men and women both use these visits. Eligibility depends on health history, other medicines, and the clinician’s judgment, and it varies by state.
What a telehealth weight visit usually involves
On a prescribing platform, people typically complete a health questionnaire. A licensed clinician reviews it and may ask follow-up questions by message or video. If a medicine is prescribed, a pharmacy fills it. DoctorsHome does not offer that visit and does not ship medication.
Safety notes
GLP-1 medicines can have serious side effects, including a possible risk of thyroid tumors. They are not appropriate for everyone, including some people with a personal or family history of certain thyroid cancers. Nausea and other stomach symptoms are commonly discussed. A clinician is the person who reviews whether any of this applies to you.
Related topics
Wegovy, Ozempic, Zepbound, Mounjaro, and Foundayo are trademarks of their owners. DoctorsHome is not affiliated with or endorsed by those companies.
Ozempic and Mounjaro are approved to treat type 2 diabetes. A clinician may consider them off-label for weight. This page does not promise weight loss or say who qualifies.
DoctorsHome publishes educational information about telehealth treatments. It is not a medical practice, clinic, pharmacy, or telehealth service. It does not diagnose, prescribe, or sell medication, and it is not a substitute for care from a licensed clinician.
Medication names on this site are examples clinicians may discuss. They are not recommendations. Availability varies by state. Nothing here is for emergencies. Call 911 for a medical emergency. If you are in a mental-health crisis, call or text 988.